Anika Therapeutics reported $167.76M in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Agenus AGEN:US USD 251.43M 37.5M
Agios Pharmaceuticals AGIO:US USD 784.94M 85.07M
Anika Therapeutics ANIK:US USD 167.76M 95K
Arrowhead Research ARWR:US USD 405.3M 27.09M
Clovis Oncology CLVS:US USD 102.21M 40.07M
Enanta Pharmaceuticals ENTA:US USD 311.71M 1.32M
Halozyme Therapeutics HALO:US USD 653.2M 111.26M
Heron Therapeutics HRTX:US USD 223.8M 29.6M
Immunogen IMGN:US USD 330.42M 63.51M
Insmed INSM:US USD 632.16M 42.56M
Intrexon XON:US USD 162.81M 1.81M
Karyopharm Therapeutics KPTI:US USD 222.68M 19.77M
Ligand Pharmaceuticals LGND:US USD 220.43M 23.35M
Macrogenics MGNX:US USD 147.81M 19.82M
Merit Medical Systems MMSI:US USD 499.86M 7.23M
Peregrine Pharmaceuticals PPHM:US USD 180.64M 612K
Rigel Pharmaceuticals RIGL:US USD 110.44M 10.08M
Sangamo Biosciences SGMO:US USD 336.62M 6.5M
Smith & Nephew PLC SN/:LN 3.76B 665M
Stryker SYK:US USD 9.32B 493M
Surmodics SRDX:US USD 57.59M 2.45M
Veracyte VCYT:US USD 238.52M 3.47M
Xencor XNCR:US USD 668M 82.06M
Zimmer Biomet Holdings Inc ZBH:US USD 4.53B 71.5M